EW — Edwards Lifesciences Share News
0.000.00%
Last trade - 00:00- $54.44bn
- $50.89bn
- $6.07bn
Edwards Lifesciences rises after co raises 2025 sales forecast
Edwards Lifesciences raises 2025 sales forecast after robust quarter (updated)
Edwards Lifesciences Corp reports results for the quarter ended March 31 - Earnings Summary
Edwards Lifesciences raises 2025 sales forecast after robust quarter
Brief: Edwards Sapien M3 Receives CE Mark, Becoming World’S First Transfemoral Transcatheter Mitral Valve Replacement System
U.S. RESEARCH ROUNDUP-Applovin, Equinix, Hubspot
U.S. STOCKS ON THE MOVE-Chefs' Warehouse, Aptose Biosciences, Electromed
U.S. STOCKS ON THE MOVE-PPG Industries, CME Group, WiSA Technologies
Edward Lifesciences rises as demand for heart device drives Q4 profit beat
Edwards Lifesciences Corp reports results for the quarter ended December 31 - Earnings Summary
Brief: Edwards Lifesciences Q4 Adjusted EPS USD 0.59 Vs. IBES Estimate USD 0.55
Edwards Lifesciences beats profit estimate on strength in heart devices
Edwards Lifesciences Corp expected to post earnings of 55 cents a share - Earnings Preview
What to Watch in the Week Ahead and on Monday, February 10
What to Watch in the Day Ahead - Tuesday, February 4
What to Watch in the Week Ahead and on Monday, February 3
Abbott forecasts first-quarter profit below estimates (updated)
Abbott forecasts in line annual profit on medical device sales
Medical device makers close 2024 with mixed stock performances